| Sunshine Act Rule Final Comments | |
| PCMA NADAC Survey Letter and Mtg Request | |
| PCMA EHB Bulletin Comment 1.31.12 | |
| PCMA Comments EHB Proposed Rule 12.26.12 | |
| PCMA Comment Letter CMS 0040 P ICD 10 NPI | |
| PCMA AMP NPRM | |
| Formulary submission date comments final | |
| FINAL PCMA OTC paradigm comments | |
| FDA biosimilars Public meeting final | |
| DUR draft guidance comments final | |
| DIR 2011 comments final | |
| Contraceptive Services ANPRM final | |
| Biosimilar guidance comments 4.16.12 | |
| 2013 Part D Call Letter comments final | |
| PCMA Reporting Requirement Comments 1.31.11 | |
| PCMA Comments Star Ratings Enhancements 1.13.12 | |
